by admin | Feb 26, 2024 | News & Opinions
By U. Rochester-URMC – Futuirity – The American Red Cross is experiencing the most critical blood shortage in 20 years. Blood shortages are all too common, but they’re occurring more frequently now than ever before. Contact the Red Cross to find local...
by admin | Feb 23, 2024 | News & Opinions
Ben Andrew Henry – The Scientist – While studying a rare genetic disease, researchers discovered a signaling pathway linked to the efficiency of reprogramming somatic cells into stem cells. Thanks to a chance discovery, researchers have found a more...
by admin | Feb 22, 2024 | News & Opinions
By Joseph Keenan – Fierce Pharma – Robotics specialist Multiply Labs and Thermo Fisher Scientific inked a deal to expand their partnership to further automate the cell therapy production process. The two companies will integrate Multiply Lab’s...
by admin | Feb 21, 2024 | News & Opinions
By Tu Wien News A new approach to producing artificial tissue has been developed at TU Wien: Cells are grown in microstructures created in a 3D printer. Is it possible to grow tissue in the laboratory, for example to replace injured cartilage? At TU Wien (Vienna), an...
by admin | Feb 20, 2024 | News & Opinions
By Andrea Park -Fierce Biotech – For the first time since it launched in 2020 and began accepting submissions in 2022, a program started by the FDA to provide support for unconventional drug development tools has accepted its first artificial...
by admin | Feb 16, 2024 | News & Opinions
by Technology Networks – Biopharma News – Initial trial suggests invariant natural killer cell therapy improves survival. Promising trial results indicate that a new type of cell therapy could improve the prognosis of those who are critically ill with...
